Dr Ruth MacKinnon – Genome Organisation and Centromeres and the Evolution of Cancerous Cell Lines

May 20, 2022 | health and medicine, trending

Original Article Reference

This SciPod is a summary of the papers ‘Genome organization and the role of centromeres in evolution of the erythroleukemia cell line HEL’ from Evolution, Medicine, and Public Health. DOI: 10.1093/emph/eot020, and ‘Detailed molecular cytogenetic characterisation of the myeloid cell line U937 reveals the fate of homologous chromosomes and shows that centromere capture is a feature of genome instability’ from Molecular Cytogenetics. DOI: https://doi.org/10.1186/s13039-020-00517-y

About this episode

There are over 3,600 established cell lines from 150 different species that can be used for scientific and medical research. In two recent studies, Dr Ruth MacKinnon and her team from St Vincent’s Hospital in Melbourne used multiple molecular methods to investigate changes in the way the genes are organised in two types of these cells. They demonstrated the importance of using multiple complementary methods and found that these cells can continue to evolve in the laboratory. They also uncovered evidence of a previously unreported process called ‘centromere capture’ which may be involved in the evolution of cancer cells.

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

More episodes

Professor Lobelia Samavati | Paving the Way for Antibody-based Diagnostics for Tuberculosis and Sarcoidosis

Professor Lobelia Samavati | Paving the Way for Antibody-based Diagnostics for Tuberculosis and Sarcoidosis

Tuberculosis – or TB – is a global health threat, with 10 million new cases annually. Diagnosing TB can be a challenge, as there is a lack of rapid, point-of-care diagnostic tests. It can also be difficult to distinguish between TB and other inflammatory diseases, such as Sarcoidosis. One option may be to identify antibodies in patient samples that can reveal the presence of TB. However, current antibody tests for TB lack accuracy. Professor Lobelia Samavati and colleagues at the Wanye State University School of Medicine in Michigan are tackling this challenge to cast light on the immune signature of these diseases. Their aim is to develop new diagnostic techniques for TB and Sarcoidosis.

Dr Abayomi Sanusi | Can Faith Institutions Encourage People to Maintain Healthy Blood Pressure?

Dr Abayomi Sanusi | Can Faith Institutions Encourage People to Maintain Healthy Blood Pressure?

High blood pressure, also known as hypertension, is a common and potentially dangerous condition that increases the risk of many severe medical issues, including heart disease, heart attack, stroke, heart failure, and kidney disease. Dr Abayomi Sanusi, a researcher at the University of York, recently carried out a study exploring how faith-based institutions could encourage their community members to adopt healthy behaviours that can reduce hypertension.

Ria Nishikawara | Exploring How to Improve Healthcare for Patients with Fibromyalgia

Ria Nishikawara | Exploring How to Improve Healthcare for Patients with Fibromyalgia

Fibromyalgia is a relatively common and yet poorly understood condition characterised by chronic diffuse pain and stiffness, chronic fatigue, poor sleep and cognitive difficulties. Ria Nishikawara at the University of British Columbia and her collaborators Dr Izabela Schultz, Dr Lee Butterfield, and John Murray, carried out a study exploring the unique healthcare experiences of patients diagnosed with fibromyalgia. Their aim was to determine what patients found most helpful and how the available services could be improved.

Addressing antimalarial drug resistance in Africa to ensure patients can continue to be saved

Addressing antimalarial drug resistance in Africa to ensure patients can continue to be saved

We are pleased to be joined by Dorothy Achu, Regional Malaria Adviser, WHO African Region; Aimable Mbituyumuremyi, Director, National Malaria Control Program, Ministry of Health, Rwanda; Adam Aspinall, Senior Director, Access and Product Management, and George Jagoe, Executive Vice-President Medicines for Malaria Venture. To learn about antimalarial drug resistance in Africa to ensure patients can continue to be saved.

Increase the impact of your research

• Good science communication helps people make informed decisions and motivates them to take appropriate and affirmative action.
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.

Step 1 Upload your science paper

Step 2 SciPod script written

Step 3 Voice audio recorded

Step 4 SciPod published